Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Aging|October 29, 2017
A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesisBela Ozsvari, Federica Sotgia, Michael P LisantiAging|February 22, 2018
Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs)Bela Ozsvari, Federica Sotgia, Michael P LisantiCancers|November 25, 2023
Novel Metabolic Approaches Targeting Cancer CellsAnna Sebestyén, Michael P Lisanti, Bela OzsvariAging|November 15, 2018
Azithromycin and Roxithromycin define a new family of "senolytic" drugs that target senescent human fibroblastsBela Ozsvari, John R Nuttall, Federica Sotgia, et al.Oncotarget|November 8, 2017
Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs)Bela Ozsvari, Federica Sotgia, Katie Simmons, et al.Aging|December 19, 2017
Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapyBela Ozsvari, Gloria Bonuccelli, Rosa Sanchez-Alvarez, et al.Cell Cycle (Georgetown, Tex.)|September 28, 2018
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RXFederica Sotgia, Bela Ozsvari, Marco Fiorillo, et al.Oncotarget|January 1, 2017
Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneityGloria Bonuccelli, Maria Peiris-Pages, Bela Ozsvari, et al.Cells|January 8, 2025
ALDHHigh Breast Cancer Stem Cells Exhibit a Mesenchymal-Senescent Hybrid Phenotype, with Elevated Metabolic and Migratory ActivitiesLuis Larrea Murillo, Conor J Sugden, Bela Ozsvari, et al.Oncotarget|October 6, 2017
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeastBela Ozsvari, Marco Fiorillo, Gloria Bonuccelli, et al.Pageof 2